Brief: Interpace Biosciences Q2 Revenue USD 12.001 Million
01/08/2024 21:30
Aug 01 (Reuters) - Interpace Biosciences Q2 operating income USD 2.216 million. * Q2 net income USD 2.021 million * Q2 operating expenses USD 5.174 million * Q2 gross profit USD 7.39 million
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million